Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    9048514 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Insulin Resistance and Atherosclerosis in Women With Lupus
Conditions: Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
2 Completed
Has Results
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Biological: Rituxan (rituximab);   Biological: filgrastim;   Drug: methylprednisolone;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: Diphenhydramine;   Drug: Mesna

Indicates status has not been verified in more than two years